173 related articles for article (PubMed ID: 27856328)
1. The therapeutic potential of iron-targeting gallium compounds in human disease: From basic research to clinical application.
Chitambar CR
Pharmacol Res; 2017 Jan; 115():56-64. PubMed ID: 27856328
[TBL] [Abstract][Full Text] [Related]
2. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
3. Gallium and its competing roles with iron in biological systems.
Chitambar CR
Biochim Biophys Acta; 2016 Aug; 1863(8):2044-53. PubMed ID: 27150508
[TBL] [Abstract][Full Text] [Related]
4. Gallium and other main group metal compounds as antitumor agents.
Jakupec MA; Keppler BK
Met Ions Biol Syst; 2004; 42():425-62. PubMed ID: 15206110
[TBL] [Abstract][Full Text] [Related]
5. Gallium in cancer treatment.
Jakupec MA; Keppler BK
Curr Top Med Chem; 2004; 4(15):1575-83. PubMed ID: 15579097
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
Chitambar CR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):39-44. PubMed ID: 15651176
[TBL] [Abstract][Full Text] [Related]
7. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.
Chitambar CR; Antholine WE
Antioxid Redox Signal; 2013 Mar; 18(8):956-72. PubMed ID: 22900955
[TBL] [Abstract][Full Text] [Related]
8. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
9. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
[TBL] [Abstract][Full Text] [Related]
10. Gallium compounds as antineoplastic agents.
Chitambar CR
Curr Opin Oncol; 2004 Nov; 16(6):547-52. PubMed ID: 15627016
[TBL] [Abstract][Full Text] [Related]
11. Gallium nitrate for the treatment of non-Hodgkin's lymphoma.
Chitambar CR
Expert Opin Investig Drugs; 2004 May; 13(5):531-41. PubMed ID: 15155128
[TBL] [Abstract][Full Text] [Related]
12. Gallium-containing anticancer compounds.
Chitambar CR
Future Med Chem; 2012 Jun; 4(10):1257-72. PubMed ID: 22800370
[TBL] [Abstract][Full Text] [Related]
13. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
14. Gallium in cancer treatment.
Collery P; Keppler B; Madoulet C; Desoize B
Crit Rev Oncol Hematol; 2002 Jun; 42(3):283-96. PubMed ID: 12050020
[TBL] [Abstract][Full Text] [Related]
15. Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Lundberg JH; Chitambar CR
Cancer Res; 1990 Oct; 50(20):6466-70. PubMed ID: 1698536
[TBL] [Abstract][Full Text] [Related]
16. Gallium-based anti-infectives: targeting microbial iron-uptake mechanisms.
Kelson AB; Carnevali M; Truong-Le V
Curr Opin Pharmacol; 2013 Oct; 13(5):707-16. PubMed ID: 23876838
[TBL] [Abstract][Full Text] [Related]
17. Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells.
Yang M; Chitambar CR
Free Radic Biol Med; 2008 Sep; 45(6):763-72. PubMed ID: 18586083
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
19. Competition between abiogenic and biogenic metal cations in biological systems: Mechanisms of gallium's anticancer and antibacterial effect.
Kircheva N; Dudev T
J Inorg Biochem; 2021 Jan; 214():111309. PubMed ID: 33212396
[TBL] [Abstract][Full Text] [Related]
20. Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects.
Timerbaev AR
Metallomics; 2009; 1(3):193-8. PubMed ID: 21305117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
